ANI Pharmaceuticals, Inc. (ANIP)
- Previous Close
66.03 - Open
66.20 - Bid 64.51 x 100
- Ask 64.83 x 100
- Day's Range
64.60 - 66.57 - 52 Week Range
43.32 - 70.81 - Volume
149,187 - Avg. Volume
159,413 - Market Cap (intraday)
1.386B - Beta (5Y Monthly) 0.81
- PE Ratio (TTM)
40.26 - EPS (TTM)
1.61 - Earnings Date Aug 7, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
81.60
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
www.anipharmaceuticals.com642
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: ANIP
Performance Overview: ANIP
Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ANIP
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ANIP
Valuation Measures
Market Cap
1.38B
Enterprise Value
1.46B
Trailing P/E
41.01
Forward P/E
15.58
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.41
Price/Book (mrq)
3.06
Enterprise Value/Revenue
2.81
Enterprise Value/EBITDA
11.50
Financial Highlights
Profitability and Income Statement
Profit Margin
6.87%
Return on Assets (ttm)
3.91%
Return on Equity (ttm)
8.71%
Revenue (ttm)
517.46M
Net Income Avi to Common (ttm)
30.55M
Diluted EPS (ttm)
1.61
Balance Sheet and Cash Flow
Total Cash (mrq)
238.25M
Total Debt/Equity (mrq)
60.93%
Levered Free Cash Flow (ttm)
79.33M
Research Analysis: ANIP
Company Insights: ANIP
ANIP does not have Company Insights